000099291 001__ 99291
000099291 005__ 20240206150120.0
000099291 0247_ $$2doi$$a10.33588/rn.7112.2020352
000099291 0248_ $$2sideral$$a121383
000099291 037__ $$aART-2020-121383
000099291 041__ $$aeng
000099291 100__ $$aBrandín-De la Cruz, N.
000099291 245__ $$aImmersive virtual reality and antigravity treadmill training for gait rehabilitation in Parkinson’s disease: A pilot and feasibility study
000099291 260__ $$c2020
000099291 5060_ $$aAccess copy available to the general public$$fUnrestricted
000099291 5203_ $$aIntroduction. Treadmill training is considered an effective intervention to improve gait ability in patients with Parkinson’s disease (PD). In parallel, virtual reality shows promising intervention with several applications in the inpatient medical setting.
Aim. To evaluate the feasibility and preliminary efficacy of mechanical gait assistance combined with immersive virtual reality in patients with PD.
Patients and methods. This pilot and feasibility study followed a pre-post study design. The intervention consisted of 12 sessions of 30 minutes, distributed regularly over four consecutive weeks. Participants walked on a treadmill with a body- weight support system set at approximately 20% of body weight and equipped with a virtual reality helmet controlled by a two-handed joystick. Feasibility and intervention outcomes were collected at baseline and after four weeks of intervention.
Results. Twelve participants of 60 patients were finally enrolled. Nine of them (75%) completed the treatment intervention with an adherence rate of 97%. Two participants left the study, one of them due to sickness associated with virtual reality and another because of a lack of motivation. There were significant differences associated with small-medium effect sizes when comparing the pre and post values for walk distance, walk speed, balance, and quality of life.
Conclusions. The present study provided preliminary evidence supporting the feasibility of the combination of antigravity treadmill and immersive virtual reality system for the rehabilitation of patients with PD.
000099291 536__ $$9info:eu-repo/grantAgreement/ES/FPI/CPB09-2018$$9info:eu-repo/grantAgreement/EC/H2020/731391/EU/Collaboration among Aerospace, Biotechnology, ICT, Energy and Medical Devices sectors in generating innovative solutions, business models and work-flows that enhance patient-centered care/Cross4Health$$9This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 731391-Cross4Health
000099291 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000099291 590__ $$a0.87$$b2020
000099291 591__ $$aCLINICAL NEUROLOGY$$b203 / 208 = 0.976$$c2020$$dQ4$$eT3
000099291 592__ $$a0.248$$b2020
000099291 593__ $$aNeurology (clinical)$$c2020$$dQ3
000099291 593__ $$aMedicine (miscellaneous)$$c2020$$dQ3
000099291 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000099291 700__ $$aSecorro, N.
000099291 700__ $$0(orcid)0000-0002-1674-7788$$aCalvo, S.
000099291 700__ $$aBenyoucef, Y.
000099291 700__ $$0(orcid)0000-0002-9201-0120$$aHerrero, P.$$uUniversidad de Zaragoza
000099291 700__ $$aBellosta-López, P.
000099291 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000099291 773__ $$g71, 12 (2020), 447-454$$pRev. neurol.$$tRevista de neurologia$$x0210-0010
000099291 8564_ $$s450083$$uhttps://zaguan.unizar.es/record/99291/files/texto_completo.pdf$$yVersión publicada
000099291 8564_ $$s2714933$$uhttps://zaguan.unizar.es/record/99291/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000099291 909CO $$ooai:zaguan.unizar.es:99291$$particulos$$pdriver
000099291 951__ $$a2024-02-06-14:56:11
000099291 980__ $$aARTICLE